메뉴 건너뛰기




Volumn 129, Issue 4, 2014, Pages 314-316

Surgeon general's perspectives

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; ANTIINFECTIVE AGENT;

EID: 84902992990     PISSN: 00333549     EISSN: 14682877     Source Type: Journal    
DOI: 10.1177/003335491412900402     Document Type: Note
Times cited : (160)

References (10)
  • 1
    • 79951821210 scopus 로고    scopus 로고
    • Clinical practice guidelines by the Infectious Diseases Society of America for the treatment of methicillin-resistant Staphylococcus aureus infections in adults and children: Executive summary
    • Liu C, Bayer A, Cosgrove SE, Daum RS, Fridkin SK, Gorwitz RJ, etal. Clinical practice guidelines by the Infectious Diseases Society of America for the treatment of methicillin-resistant Staphylococcus aureus infections in adults and children: executive summary. Clin Infect Dis 2011;52:285-92.
    • (2011) Clin Infect Dis , vol.52 , pp. 285-292
    • Liu, C.1    Bayer, A.2    Cosgrove, S.E.3    Daum, R.S.4    Fridkin, S.K.5    Gorwitz, R.J.6
  • 2
    • 84874894245 scopus 로고    scopus 로고
    • Vital signs: Carbapenem-resistant Enterobacteriaceae
    • Vital signs: Carbapenem-resistant Enterobacteriaceae. MMWR Morb Mortal Wkly Rep 2013;62(9):165-70.
    • (2013) MMWR Morb Mortal Wkly Rep , vol.62 , Issue.9 , pp. 165-170
  • 3
    • 0003564810 scopus 로고    scopus 로고
    • Antibiotic resistance threats in the United States, Atlanta: CDC; 2013. Also available from, cited 2014 Apr 18
    • Centers for Disease Control and Prevention (US). Antibiotic resistance threats in the United States, 2013. Atlanta: CDC; 2013. Also available from: URL: http://www.cdc.gov/drugresistance/threat-report-2013 [cited 2014 Apr 18].
    • (2013) Centers For Disease Control and Prevention (US)
  • 4
    • 84858598560 scopus 로고    scopus 로고
    • Vital signs: Preventing Clostridium difficile infections
    • Vital signs: preventing Clostridium difficile infections. MMWR Morb Mortal Wkly Rep 2012; 61(9): 157-62.
    • (2012) MMWR Morb Mortal Wkly Rep , vol.61 , Issue.9 , pp. 157-162
  • 5
    • 78651088658 scopus 로고    scopus 로고
    • Antimicrobial stewardship for inpatient facilities
    • Ohl CA, Luther VP. Antimicrobial stewardship for inpatient facilities. J Hosp Med 2011; 6 Suppl 1: S4-15.
    • (2011) J Hosp Med , vol.6 , Issue.SUPPL. 1
    • Ohl, C.A.1    Luther, V.P.2
  • 6
    • 84897800564 scopus 로고    scopus 로고
    • Vital signs: Improving antibiotic use among hospitalized patients
    • Vital signs: improving antibiotic use among hospitalized patients. MMWR Morb Mortal Wkly Rep 2014; 63(9): 194-200.
    • (2014) MMWR Morb Mortal Wkly Rep , vol.63 , Issue.9 , pp. 194-200
  • 8
    • 33846153776 scopus 로고    scopus 로고
    • Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America guidelines for developing an institutional program to enhance antimicrobial stewardship
    • Dellit TH, Owens RC, McGowan JE Jr, Gerding DN, Weinstein RA, Burke JP, et al. Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America guidelines for developing an institutional program to enhance antimicrobial stewardship. Clin Infect Dis 2007; 44: 159-77.
    • (2007) Clin Infect Dis , vol.44 , pp. 159-177
    • Dellit, T.H.1    Owens, R.C.2    McGowan Jr., J.E.3    Gerding, D.N.4    Weinstein, R.A.5    Burke, J.P.6
  • 9
    • 77953917693 scopus 로고    scopus 로고
    • Effect of antibiotic prescribing in primary care on antimicrobial resistance in individual patients: Systematic review and meta-analysis
    • Costelloe C, Metcalfe C, Lovering A, Mant D, Hay AD. Effect of antibiotic prescribing in primary care on antimicrobial resistance in individual patients: systematic review and meta-analysis. BMJ 2010; 340:c2096.
    • (2010) BMJ , vol.340
    • Costelloe, C.1    Metcalfe, C.2    Lovering, A.3    Mant, D.4    Hay, A.D.5
  • 10
    • 84878278251 scopus 로고    scopus 로고
    • 10 x '20 Progress-development of new drugs active against gram-negative bacilli: An update from the Infectious Diseases Society of America
    • Boucher HW, Talbot GH, Benjamin DK Jr, Bradley J, Guidos RJ, Jones RN, et al. 10 x '20 Progress-development of new drugs active against gram-negative bacilli: an update from the Infectious Diseases Society of America. Clin Infect Dis 2013;56:1685-94.
    • (2013) Clin Infect Dis , vol.56 , pp. 1685-1694
    • Boucher, H.W.1    Talbot, G.H.2    Benjamin Jr., D.K.3    Bradley, J.4    Guidos, R.J.5    Jones, R.N.6


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.